Shenzhen Hepalink Pharmaceutical Co Ltd (002399) — Cash Flow Reinvestment Rate
Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Cash Flow Reinvestment Rate of 0.03x as of September 2025, reinvesting CN¥13.60 Million (capex CN¥13.60 Million ) from operating cash flow of CN¥399.43 Million. Explore 002399 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Shenzhen Hepalink Pharmaceutical Co Ltd across 16 annual periods. Also explore how large is Shenzhen Hepalink Pharmaceutical Co Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)
Year-by-year capital reinvestment analysis for Shenzhen Hepalink Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Shenzhen Hepalink Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | CN¥763.43 Million | CN¥1.71 Billion | CN¥121.10 Million | ▲ +287.0% |
| 2024 | 0.12x | CN¥252.68 Million | CN¥2.19 Billion | CN¥202.77 Million | ▼ -97.2% |
| 2023 | 4.18x | CN¥1.67 Billion | CN¥398.22 Million | CN¥444.88 Million | ▼ -93.1% |
| 2020 | 60.36x | CN¥2.25 Billion | CN¥37.28 Million | CN¥212.49 Million | ▲ +1329.2% |
| 2018 | 4.22x | CN¥2.82 Billion | CN¥667.87 Million | CN¥535.01 Million | ▲ +131.1% |
| 2016 | 1.83x | CN¥632.55 Million | CN¥346.07 Million | CN¥359.54 Million | ▲ +867.4% |
| 2015 | 0.19x | CN¥168.85 Million | CN¥893.71 Million | CN¥168.85 Million | ▲ +2.9% |
| 2014 | 0.18x | CN¥167.62 Million | CN¥912.80 Million | CN¥167.62 Million | ▼ -73.7% |
| 2013 | 0.70x | CN¥293.98 Million | CN¥420.97 Million | CN¥293.98 Million | ▲ +39.3% |
| 2012 | 0.50x | CN¥237.55 Million | CN¥473.89 Million | CN¥237.55 Million | ▲ +425.0% |
| 2011 | 0.10x | CN¥134.16 Million | CN¥1.41 Billion | CN¥134.16 Million | ▼ -5.7% |
| 2010 | 0.10x | CN¥35.93 Million | CN¥354.86 Million | CN¥35.93 Million | ▼ -34.4% |
| 2009 | 0.15x | CN¥54.91 Million | CN¥355.81 Million | CN¥54.91 Million | ▼ -42.7% |
| 2008 | 0.27x | CN¥10.81 Million | CN¥40.13 Million | CN¥10.81 Million | ▼ -68.8% |
| 2007 | 0.86x | CN¥11.95 Million | CN¥13.85 Million | CN¥11.95 Million | ▲ +477.7% |
| 2006 | 0.15x | CN¥10.71 Million | CN¥71.66 Million | CN¥10.71 Million | — |